Hepatitis B Immunoglobulin Immunoprophylaxis for Hepatitis B: High, Low, or No Dose?

被引：3

作者：

Gane, Ed ^{[1
]}

机构：

[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland 1001, New Zealand

来源：

LIVER TRANSPLANTATION | 2010年 / 16卷

关键词：

LIVER-TRANSPLANT RECIPIENTS; RECEIVING LAMIVUDINE PROPHYLAXIS; ADEFOVIR DIPIVOXIL; VIRUS RECURRENCE; PASSIVE IMMUNOPROPHYLAXIS; COMBINATION; PREVENTION; PLUS; IMMUNIZATION; VACCINATION;

D O I：

10.1002/lt.22151

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Key Points 1. Transplantation for HBV-related HCC is increasing in the West, whilst HBV-relate liver failure is decreasing. 2. Combination lamivudine plus HBIG reduces the risk of HBV recurrence to less than 5%. 3. Low-dose IM HBIG ihas similar efficacy and better cost effectiveness than high-dose IV HBIG when combined with oral nucleos(t)ide therapy. 4. HBIG may be discontinued in low risk recipients (undetectable HBV DNA prior to transplant). 5. Combination of new potent antivirals without cross resistance may minimise the future need for post-operative HBIG. Liver Transpl 16:S36-S39, 2010. copy; 2009 AASLD. Copyright © 2009 American Association for the Study of Liver Diseases.

引用

页码：S36 / S39

页数：4

共 27 条

[1] A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis
Angus, Peter W.
Patterson, Scott J.
Strasser, Simone J.
McCaughan, Geoffrey W.
Gane, Edward
[J]. HEPATOLOGY, 2008, 48 (05) : 1460 - 1466
[2] Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation
Bock, CT
Tillmann, HL
Torresi, J
Klempnauer, J
Locarnini, S
Manns, MP
Trautwein, C
[J]. GASTROENTEROLOGY, 2002, 122 (02) : 264 - 273
[3] Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
Burbach, GJ
Bienzle, U
Neuhaus, R
Hopf, U
Metzger, WG
Pratschke, J
Neuhaus, P
[J]. TRANSPLANTATION, 1997, 63 (03) : 478 - 480
[4] Adherence to lamivudine after an early withdrawal of hepatitis B immune. globulin plays an important role in the long-term prevention of hepatitis B virus recurrence
Buti, Maria
Mas, Antoni
Prieto, Martin
Casafont, Fernando
Gonzalez, Antonio
Miras, Manuel
Herrero, Jose Ignacio
Jardi, Rosendo
Esteban, Rafael
[J]. TRANSPLANTATION, 2007, 84 (05) : 650 - 654
[5] Prophylactic strategies for hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis
Dan, Yock Young
Wai, Chun Tao
Yeoh, Khay Guan
Lim, Seng Gee
[J]. LIVER TRANSPLANTATION, 2006, 12 (05) : 736 - 746
[6] Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: A highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation
Di Paolo, D
Tisone, G
Piccolo, P
Lenci, I
Zazza, S
Angelico, M
[J]. TRANSPLANTATION, 2004, 77 (08) : 1203 - 1208
[7] Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
Fontana, RJ
Hann, HWL
Perrillo, RP
Vierling, JM
Wright, T
Rakela, J
Anschuetz, G
Davis, R
Gardner, SD
Brown, NA
[J]. GASTROENTEROLOGY, 2002, 123 (03) : 719 - 727
[8] Gane E, 2007, HEPATOLOGY, V46, p479A
[9] Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Gane, Edward J.
Angus, Peter W.
Strasser, Simone
Crawford, Darrell H. G.
Ring, John
Jeffrey, Gary P.
McCaughan, Geoffrey W.
[J]. GASTROENTEROLOGY, 2007, 132 (03) : 931 - 937
[10] Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients:: Antibody decline and booster vaccination with conventional vaccine
Günther, M
Neuhaus, R
Bauer, T
Jilg, W
Holtz, JA
Bienzle, U
[J]. LIVER TRANSPLANTATION, 2006, 12 (02) : 316 - 319

← 1 2 3 →